PF4 and synovial sarcoma: Platelet factor 4 (PF4), which is present in high concentrations in d-MAPPSTM, limits the generation of Th17 cells and is crucially involved in the suppression of Th17-cell-driven inflammation in the eyes of SLE, RA, or SS patients [11,42].